SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — Paul Robeson

PatientPaul Robeson
Date of birth1967-04-09
IdentifiersMRN HR-ML048-SYN; SSN (made up) 000-48-2647
Document date2026-07-27
AuthorTheodore Bankole-Ashworth, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Cough for five days after a cold. [S]

History of Present Illness

Mr. Robeson called this morning and was seen the same day. A week ago he had a sore throat and a runny nose, and for five days he has had a cough, worse at night, with a little clear sputum. He has had no fever, breathlessness, chest pain or blood in the sputum. The cough is keeping him awake and he wants to protect his voice. He bought a nighttime cold medicine but did not take it after reading that it contained dextromethorphan and remembering the warning about venlafaxine. He takes venlafaxine 225 mg each morning, three weeks at the full dose, with mild sweating and no other side effects. His mood is a little better than in the spring; he goes to his therapy sessions each week and walks most mornings. He has had no thoughts of suicide or of being better off dead. [S]

ElementDetail
OnsetCough for five days after a cold a week ago
CharacterCough with a little clear sputum, worse at night
SeverityDisturbing his sleep; no breathlessness
ContextVenlafaxine 225 mg daily; has avoided a dextromethorphan cold remedy
Associated signs and symptomsNo fever, chest pain or blood in the sputum

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or chills; tired from broken sleep
Ears, nose, mouth, and throatPositiveSore throat and runny nose last week, now settling; voice a little hoarse
RespiratoryPositiveCough with clear sputum; no wheeze, breathlessness or hemoptysis
CardiovascularNegativeNo chest pain or palpitations
PsychiatricPositiveMood low but improving; no thoughts of suicide

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg tablet, one tablet each morning50 mg each morning for two weeksOral route2026-03-12 to 2026-03-25completedS
Sertraline 100 mg tablet, one tablet each morning100 mg each morningOral route2026-03-26 to 2026-04-19completedS
Sertraline 50 mg tablets, three tablets (150 mg) each morning150 mg each morning for two weeksOral route2026-04-20 to 2026-05-03completedS
Sertraline 100 mg tablets, two tablets (200 mg) each morning200 mg each morningOral route2026-05-04 to 2026-06-07completedS
Sertraline 100 mg tablet, one tablet each morning for one week, then stop100 mg each morning for one week during the switchOral route2026-06-08 to 2026-06-14completedS
Venlafaxine extended-release 75 mg capsule, one capsule each morning with food75 mg each morning for one weekOral route2026-06-08 to 2026-06-14completedS
Venlafaxine extended-release 150 mg capsule, one capsule each morning with food150 mg each morning for three weeksOral route2026-06-15 to 2026-07-05completedS
Venlafaxine extended-release 75 mg capsules, three capsules (225 mg) each morning with food225 mg each morning; 30-day supply at a timeOral route2026-07-06activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-27Body height190cmS
2026-07-27Body weight100.6kgS
2026-07-27Body mass index (BMI) [Ratio]27.9kg/m2S
2026-07-27Systolic blood pressure132mm[Hg]S
2026-07-27Diastolic blood pressure82mm[Hg]S
2026-07-27Heart rate84/minS
2026-07-27Respiratory rate16/minS
2026-07-27Body temperature37.4CelS
2026-07-27Oxygen saturation in Arterial blood by Pulse oximetry97%S

Physical Exam

Vital signs recorded on 2026-07-27; see the Vital Signs section. [S]

SystemFinding
GeneralComfortable; temperature 37.4 °C, pulse 84, respiratory rate 16, oxygen saturation 97 percent, blood pressure 132/82
Ears, nose, mouth, and throatMild pharyngeal redness; no exudate; ears normal
RespiratoryScattered rhonchi that clear with coughing; no crackles, wheeze or bronchial breathing
CardiovascularRegular rhythm
PsychiatricCalm, brighter than in the spring; no thoughts of suicide

Problems

ProblemClinical statusVerificationCodeProvenance
About three months of low mood, exhaustion, poor sleep with waking at three in the morning, loss of interest in singing and reading, poor appetite with 5 kg weight loss, and withdrawal from friends, in a man of 58 under sustained political pressure; PHQ-9 22 with thoughts of being better off dead; depression suspected; medical causes being excluded and urgent psychiatric consultation arrangedresolvedconfirmed R53.83S — Synthetic presenting problem at intake, superseded by the diagnosis at the psychiatric consultation; anchored to his documented depression and loss of work (D).
Major depressive disorder, recurrent, severe, without psychotic features (second episode; structured diagnostic interview; MDQ negative and no past hypomanic or manic episode on interview)activeconfirmed F33.2S — Synthetic modern diagnosis anchored to his documented depression after the 1955 breakdown (D); the bipolar interpretation (R) is addressed and not adopted.
Sustained political persecution: passport withheld, concerts and recordings cancelled, income lost, and surveillance by federal agencies; a major and realistic stressor, not a delusionactiveconfirmed Z60.5S — Synthetic coding of his documented persecution as a social determinant of his depression.
Acute bronchitis after a cold, without signs of pneumonia; treated without antibiotics and without dextromethorphan or decongestants because of venlafaxine; resolvedactiveconfirmed J20.9S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016)

Follow-up: Twenty-four-week review in four weeks as booked. Return sooner for fever or breathlessness. Call or text 988 at any time in a crisis. Next scheduled visit 2026-08-24: twenty-four-week review: partial response to venlafaxine; treatment-resistant depression; aripiprazole augmentation and an informed consent discussion about ECT. [S]